But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Your COPD is considered to be moderate ... s stage allows your doctor to recommend and prescribe the best possible treatment. While staging helps create standard treatments, your doctor will ...

COPD is the third leading cause of death worldwide ... we'll make sure that families everywhere never face a lung condition without the best treatment and care." More information: Monoclonal ...

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the CHEST ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.